Smart watches and devices are making more people aware of their irregular heartbeats. In fact, in some cases, they are leading to a common condition being diagnosed sooner: Atrial Fibrillation, ...
Dutch trial establishes feasibility of screening approach in routine specialty care ...
A new clinical study suggests the Apple Watch may be more effective at detecting atrial fibrillation than standard medical ...
New peer-reviewed research shows Apple Watch detected 4x more AFib cases than standard care, including 57% of people with no ...
Smartwatch-based monitoring using both photoplethysmography and ECG could improve detection of new-onset atrial fibrillation ...
A landmark clinical trial from St Bartholomew’s Hospital reveals that the Apple Watch detects recurring AFib faster and reduces unplanned hospitalizations by half following catheter ablation.
The Apple Watch has plenty of potential for health monitoring even after discovery of a condition, and a new study outlines ...
Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...
- As the world’s first ring-type medical device to monitor heart signals, CART-I continually measures atrial fibrillation 24/7 - In-house developed AI technology is used to provide significant medical ...
As the use of wearable technology grows, smart watches are marketed across the globe to consumers as a way to monitor health. For some, they’re told by these devices that they have atrial fibrillation ...
AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial ...